chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever is 99.8 last when I checked; Severe stomach ache; Nauseous; Pressure in my back, kind of mid to higher back, so there is a lot of pressure; Very tired; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: Unknown), via an unspecified route on 07Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 14Mar2021, the patient experienced very tired and on 15Mar2021 fever is 99.8 last when checked, severe stomach ache, nauseous, pressure in back, kind of mid to higher back, so there is a lot of pressure. Consumer stated, "So I received my first vaccine a week ago on Sunday, so then today is the eighth day and I didn't have any side effects on the first day but I was just very tired yesterday. Today I have a slight fever. I think it is 99.8 last when I checked and I am having a such a severe stomach ache, I am nauseous which I know that is common but I am feeling a lot of pressure like the stomach ache is not, doesn't feel like a normal stomach ache, it's kind of pressure is very high. I feel like some pressure in my back, kind of mid to higher back. So there is a lot of pressure." The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
After receiving Anthrax and Twinrix vaccines, pt stated that he didn't feel well and immediately fell to the floor from a sitting position. Pt was sitting on an exam table and fell forward hitting his head on the floor. Pt was unresponsive for a few seconds but regained conciousness without immediate memory of what happened. Pt was c/o pain to back of head radiating down neck despite hitting the front of his head. Pt was observed and monitored in the immunization room. Vitals and ABC's were recorded. Pt was re-evaluated by a second provider after being observed for 10 minutes. Pt was eventually cleared and left the clinic SIQ.
At 1620 the client received both Tdap & Influenza vaccines. The client reporting having a fear of needles prior to administration. He denied adverse reaction to vaccine / medicine in his history. At 1630 the client became "dizzy lightheaded". He proceeded to sit on the floor. A near syncopal episode experienced 1635 VS: BP - 108/66; 1650 BP - 132/88: client stabilized; no treatment given; sips of water only. Instructed to perform deep breathing exercises.
Rash and itching of left abdomen. Began 36-38 hours after vaccine
Approximately 20 hours from administration of vaccine I developed a low grade fever of 100.3, body aches, headache, abdominal pain, and chills. At approximately 26 hours from administration my temperature (verified on 2 thermometers with my husband acting as control) my tympanic temperature was 105.4. Despite alternating Tylenol and ibuprofen, my fever continued to rise and peaked at 107.1 at approximately 30 hours from administration. Again, this was verified on 2 tympanic thermometers and my husband, who did not receive a vaccine, registered in the normal range with the same thermometers. I am a nurse and would not have believed it if I'd not seen it with my own eyes. I was alert and oriented throughout the night. I experienced severe chills and body aches and severe headache.  Fever went down to 104 after a cool bath and cold compresses and the following day, 10/2,  it stayed at 101-102. I continued to experience the same symptoms, just reduced, for the following  2 days, with a temp max of 100.3. Today, on day 5, my temperature is 99.5. I no longer have chills or body aches but do continue to have abdominal pain and fatigue.
Felt hot around injection side, pain and armpit  and including (R) breast area. Pain subsided by 10/10. TYLENOL.
Patient had rash red and elevated. Cleared mostly within 1 hour. Didn't seem to be itchy. No new foods. No cold or cough.
Diagnosed with shingles one week to the day post second dose of Pfizer Covid 19 Vaccine.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Pharmacist).  A 66-year-old male patient received BNT162b2 (BNT162B2), on 04Mar2021 as dose 1, single (Batch/Lot number: unknown), on 25Mar2021 as dose 2, single (Batch/Lot number: unknown), on 22Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 31Mar2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 66 years for covid-19 immunisation. The patient's relevant medical history included: "CAD" (unspecified if ongoing); "HTN" (unspecified if ongoing). The patient's concomitant medications were not reported. The patient had no known drug allergies.  The following information was reported: VACCINATION FAILURE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "recovering" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: The device timestamp was reported as 01Aug2022. The patient was treated with Paxlovid orally for Covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provide and plausible temporal association, the causality between BNT162B2 and events cannot be completely excluded.
Four by five cm area of erythema and papular eruption (almost vesicular) with multiple satellite lesions.
Female-8 month old was given KINRIX instead of just DTAP per recommendation of an urgent care. Mother dose not immunize but 8 month old was bitten by a rabbit and was advised to get DTAP once at least. No consent was signed before mother left and mother only wished to get DTAP only. KINRIX was given by mistake. MA-C thought they had drawn up DTAP only but was combo IPV and DTAP. MA did not make sure mother signed consent prior to her administering or leaving. Tried contacting mother but BAD # in chart for pt. so letter sent out with information. Risk management and GlaxoSmithKline the manufacturer were also involved.
Endurative on upper Right Thigh 1 hr. after injection given. severe itching swelling. 7 x used ice 7 x 12 cm
Immediately following administration of vaccine, patient was still in chair, became pale, diaphoretic, had pre-syncopal episode.  Regained consciousness, did not fall.  Placed in WC, transported to OBS area, completely alert and talking with parents and staff.  Patient consumed gatorade, feels well.  Finished 30 min obs period without incident.  Left with parents feeling well.
Received pneumonia after getting this vaccine; Received pneumonia after getting this vaccine; This is a spontaneous report from a contactable pharmacist. A female patient of an unspecified age received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration in 2017 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient received a PCV-13 in 2017 and believed she 'received pneumonia' on an unknown date after getting this vaccine. The reporter would like for Pfizer to call the patient back to clarify that additional pneumonia vaccines may be recommended in addition to the single PCV-13 that was recommended. Patient was refusing to get a PPSV23 immunization due to thinking she only needed one pneumonia vaccine. The outcome of the event was unknown.  Information on the batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with pneumococcal 13-valent conjugate vaccine in this patient cannot be completely excluded.  Further information like confirmative pathological/serotype results are needed for full medical assessment.
It was reported that a 2 month old male received a DTAP-Tripedia vaccination on 9/27/99 and reportedly, that same day, the pt experienced inconsolable crying for 2 hours. The pt was given Tylenol and the experience resolved. It was stated, "The doctor is not concerned and is not filing a VAERS report".
nauseous, she thought it was stomach flu; really ached whenever she moved her arm; became really sick with fever; chills; headache; pain in left arm (injection site pain)/ Arm pain described as high rate of pain; swollen arm; nauseous, she thought it was stomach flu; This case was reported by a consumer and described the occurrence of fever in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included anaphylactoid shock (after she took Lodine).   In October 2020, the patient received the 2nd dose of Shingrix (intramuscular). In October 2020, 6 hrs after receiving Shingrix, the patient experienced fever, chills, headache, pain in arm, swelling arm, nausea, stomach flu and pain upon movement. In October 2020, the outcome of the fever, chills, headache, pain in arm, swelling arm, nausea, stomach flu and pain upon movement were recovered/resolved.   It was unknown if the reporter considered the fever, chills, headache, pain in arm, swelling arm, nausea, stomach flu and pain upon movement to be related to Shingrix.  Additional details were provided as follows: The patient reported for herself. The patient was really sick with fever, chills and headache. She also experienced pain in left arm (injection site pain, never got red but it was swollen and really ached whenever she moved her arm.. The arm pain described as high rate of pain.  The patient felt nauseous, she thought it was stomach flu. The lot number was unknown and reporter said she would call back with lot number.  The reporter consented to follow up.
gen aching, nausea & fever, t102, pulse 108;BP 140/72; tx APAP & Ibuprofen;
On the day of the vaccine, all I had was the common shoulder ache and mild bilateral knee pain.  The next day I woke up with terrible pain in my spine from about the mid cervical spine to the mid thoracic spine.  It felt like it was in the vertebrae as opposed to a muscle and kept me in bed most of the day and I missed work (which is rare for me).      I then had return of nerve pain in my neck and arms and patchy intermittent numbness in both arms (only the right arm was affected in 2019, but I have more pinched nerves on the left).  The symptoms  resolved in maybe 3-6 weeks after the vaccine and the pain in my neck mostly resolved within about 2-3 months.  My hunch is I just had a severe inflammatory response that made areas with stenosis even smaller, encroaching on the nerve roots
Redness in the shape of a circle about the size of silver dollar.  Tender to touch.  Feverish to touch, but no other pain.  Tends to be decreasing in color and size.
Patient presented at clinic with symptoms 48 hours after shot was administered, states reaction started 24 hours after the shot. Sedation, myalgia, rash and left arm pain, redness, swelling, hot to touch; overall fatigue, sweats, chills, muscle and joint pain. Diphenhydramine mg PRN.
Pt has chicken pox disease, has not had vaccine due to age. Follow up: This child was not old enough to receive the vaccine. He did have the chickenpox disease. I spoke with reporter on this matter. Patient was almost 6 monts old when he got he chickenpox. Therefore no vaccine info or NFR Info is available.
Severe stomach cramps.  Vomiting and diarrhea. Lasting 6hrs.  Ongoing headache, weakness and soreness from extreme vomiting.  The afternoon starting to feel better.  Only drinking liquids for rehydration.  Some crackers. Taking. Ibuprofen for headache.
I got covid the day after I got the second booster.also my sister had the same thing happen to her she got covered id righ\t after the second Moderna booster a week before.we both thought our symptoms were side effects but we both came down with covid, quite a coincidence
Fell right over upon getting up in bed; Dizziness; Headache; Tiredness; Injection site appears black and blue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Injection site appears black and blue), FALL (Fell right over upon getting up in bed), DIZZINESS (Dizziness), HEADACHE (Headache) and FATIGUE (Tiredness) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Osteoporosis and Dyslipidemia. Concomitant products included ROSUVASTATIN for Dyslipidemia, CALCIUM CITRATE for Osteoporosis.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Injection site appears black and blue), DIZZINESS (Dizziness), HEADACHE (Headache) and FATIGUE (Tiredness). On 27-Mar-2021, the patient experienced FALL (Fell right over upon getting up in bed). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOLOURATION (Injection site appears black and blue), DIZZINESS (Dizziness), HEADACHE (Headache) and FATIGUE (Tiredness) was resolving and FALL (Fell right over upon getting up in bed) outcome was unknown.            Treatment details included Tylenol.   This case was linked to MOD-2021-059621 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow up was added on 12 May 2021 and AE contact information was updated.
Pinched nerve pain. BP 145/68 (pulse 70), O2 sat 100%.
No patient adverse event - patient received Pfizer Bivalent Booster dose as primary dose instead of Moderna primary series.
pt recv vax 4AUG95; pt reports onset of sx 12AUG lasting through 16AUG of gen achiness, fever (temp never recorded), cold sweats, itchy rash & faintness; 17AUG pt reported sx to the clinic; pt examined by MD dx as an allerg vax rxn;
Pharmacy inadvertently sent expired Covid vaccine to our facility for administration on 2/15/2023; which was unknown by our facility until 5/2/2023.
VERY DIZZIE AND NOT FEELING WELL.   AFTER TESTS I FOUND FROM MY DOCTOR THAT ALTOUGH I DIDN'T KNOW IT I'VE HAD COVID AND HAD MORE THAN ENOUGHT ANTIBODIES.  SINCE I DIDN'T KNOW I WENT TO GET THE THIRD VACCINE AND MY ANTIBODIES ARE THROUGH THE ROOF.
Patient's father came into pharmacy to get his annual vaccine. He told our staff patient experienced some issues the day after getting her Pfizer Monovalent Covid Vaccine. She was taken to the hospital and diagnosed with Guillain-Barre Syndrome. She has been treat in is recovering per her father.
fatigue, headache, light headedness- left work early, slept off and on for the remainder of the day
Patient reports later in the evening after receiving second dose of Pfizer vaccine she developed severe left arm pain.  Reports she could barley move her left arm.  Team member states left arm pain has resolved. Patient reports she also developed migraine, diarrhea, vomiting, with decreased appetite.  Reports intermittent chest tightness, but denies chest pain, heart palpitations, or shortness of breath.  Reports she is tolerating some food and liquids by mouth such as veggies, fruits, and smoothies.  Patient states she recently tested positive for COVID on 1/7/22.
booster; trouble breathing; weakness; it worsened; some kind of infection; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team.  A 80 year-old male patient received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1; Primary Immunization series complete but unknown manufacturer); Covid-19 vaccine (Dose 2; Primary Immunization series complete but unknown manufacturer). The following information was reported: IMMUNISATION (hospitalization) with onset Nov2021, outcome "unknown", described as "booster"; DYSPNOEA (hospitalization) with onset 2021, outcome "unknown", described as "trouble breathing"; ASTHENIA (hospitalization) with onset 2021, outcome "unknown", described as "weakness"; CONDITION AGGRAVATED (hospitalization) with onset 2021, outcome "unknown", described as "it worsened"; INFECTION (hospitalization) with onset 2021, outcome "unknown", described as "some kind of infection". The patient was hospitalized for dyspnoea, asthenia, condition aggravated, infection (start date: 2021); the patient was hospitalized for immunisation (start date: 2021). HCP reported that she was not sure when did the patient received the booster dose but she knows it was a week before holiday. After the patient received the booster dose he experienced trouble breathing and weakness, it worsened and the patient is in the hospital currently. They were told that there's some kind of infection through patient body but they can't find and identify what infection it was.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.; Sender's Comments: Based on possible temporal association the causal role of BNT162B2 Vaccine cannot be excluded for reported events .Case will be reviewed further on receipt of FU information  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
Headache, Blurry vision, nausea, vertigo, light headed, fatigue
Soreness in her right arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness in her right arm) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Soreness in her right arm). At the time of the report, VACCINATION SITE PAIN (Soreness in her right arm) outcome was unknown. Not Provided          No concomitant medication provided. No treatment information mentioned.  Action taken with respect to mRNA-1273 was not applicable.
Pt got shots, that time he was fine. After couple of hrs he felt dizzy, later at night it worst, but he slept well last night. Today morning again dizziness. So he called here, and complain about dizziness. He was not sure why it happened. Last year he got FLUZONE HD and PREVNAR, nothing happened. I as pharmacist told him to check blood pressure and blood sugar. Again i called in the evening at 6.30 pm, he is still dizzy but less severe. He contacted his daughter who is nurse,  told him to drink lots of water and just watch for symptoms. If too severe go urgent care.
A round bruise appeared three days after getting vaccinated and bruise was still clearly visible 11 days post-vaccination (10/12/2021.)
I woke up during the night, after the shot was administered with chills, fever of 101 F, achy muscles, stuffy head and ears. There was swelling and soreness at the site of injection the first day, and I was very tired for 2 days, improving on the 2nd day, and feeling normal on the 3rd day. With my 1st Shingrix vaccination, of 11/6/2019, I only had the soreness and swelling at the site.
Post vax, the patient's face became bright red. The patient was crying and within seconds her face became blotchy. While being examined, small pinpoint raised spots appeared with large irregular splotches and raised bumps. The rash spread all over the patient's entire body within 5-8 minutes. Circumoral cyanosis was noted.
Information has been received from a physician's assistant concerning a 15 year old female with no pertinent medical history or drug reactions/allergies on 22-AUG-2007 was vaccinated with a first dose of Gardasil (lot#655617/1447F) IM. There was no concomitant medications. In August 2007 the patient experienced cessation of menstruation. Medical attention was sought. The patient was seen by the physician's assistant in December 2007 and still did not start menstruating. In January 2008, the patient had "some spotting". On an unspecified date the patient had a thyroid function test performed and was negative. At the time of reporting the patient had not recovered. No further information was provided. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 60 years old female patient with no pertinent medical history or drug reactions/allergies. The patient was vaccinated IM. into deltoid instead of subcutaneous with a dose of ZOSTAVAX on approximately 17-AUG-2012 (reported as "1 to 2 weeks ago"). No other co-suspects were reported. No concomitant medications were reported. In August 2012 (reported as "couple days after injection") the patient experienced redness and swelling at injection site. No treatment information was reported. The relatedness for redness and swelling at injection site was unknown for ZOSTAVAX. No lab diagnostics were performed. The patient had contacted pharmacist. At the time of report, the patient was recovering. Additional information has been requested.